Autism Spectrum Disorder Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Therapy (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others), By Disease (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), By Age Group (Children and Adults), By Distribution Channel (Hospital Pharmacies, Drugs Stores & Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2023-2030

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 7.9% from 2023 to 2030

Unit

Value (USD billion)

Segmentation

By Drug Therapy, Disease, Age Group, Distribution Channel, and Geography

By Drug Therapy

• Antipsychotic Drugs
• SSRIs/Antidepressants
• Stimulants
• Sleep Medications
• Others 

By Disease

• Autistic Disorder
• Asperger Syndrome
• Pervasive Developmental Disorder (PDD)
• Others

By Age Group

• Children
• Adults

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

By Geography

• North America (By Drug Therapy, By Disease, By Age Group, By Distribution Channel, and By Country)
  • U.S. (By Disease)
  • Canada (By Disease)
• Europe (By Drug Therapy, By Disease, By Age Group, By Distribution Channel, and By Country/Sub-Regions)
  • U.K. (By Disease)
  • Germany (By Disease)
  • France (By Disease)
  • Italy (By Disease)
  • Spain (By Disease)
  • Scandinavia (By Disease)
  • Rest of Europe (By Disease)
• Asia Pacific (By Drug Therapy, By Disease, By Age Group, By Distribution Channel, and By Country/Sub-Regions)
  • China (By Disease)
  • Japan (By Disease)
  • India (By Disease)
  • Australia (By Disease)
  • Southeast Asia (By Disease)
  • Rest of Asia Pacific (By Disease)
• Latin America (By Drug Therapy, By Disease, By Age Group, By Distribution Channel, and By Country/Sub-Regions)
  • Brazil (By Disease)
  • Mexico (By Disease)
  • Rest of Latin America (By Disease)
• The Middle East & Africa (By Drug Therapy, By Disease, By Age Group, By Distribution Channel, and By Country/Sub-Regions)
  • GCC Countries (By Disease)
  • South Africa (By Disease)
  • Rest of the Middle East & Africa (By Disease)